[Zidovudine efficacy and tolerance in 32 patients with cerebral toxoplasmosis in the acquired immunodeficiency syndrome].
Leport
C
C
Chakroun
M
M
Matheron
S
S
Rozenbaum
W
W
Dournon
E
E
Regnier
B
B
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000328:Adult; D001927:Brain Diseases / Q000188:drug therapy*; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D014123:Toxoplasmosis / Q000188:drug therapy*; D015215:Zidovudine / Q000627:therapeutic use*
D015215:Zidovudine
Efficacité et tolérance de la zidovudine chez 32 malades atteints de toxoplasmose cérébrale au cours du syndrome dímmunodéficit acquis.